These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30627777)

  • 1. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
    Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z; Li F; He S; Zhao L; Wang F
    Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
    Jiang L; Shi S; Li F; Shi Q; Zhong T; Zhang H; Xia Y
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells.
    Li X; Zhao J; Yan T; Mu J; Lin Y; Chen J; Deng H; Meng X
    J Food Sci; 2021 Jun; 86(6):2700-2712. PubMed ID: 33908630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
    Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M
    Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
    Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin.
    Feng Y; Zou W; Hu C; Li G; Zhou S; He Y; Ma F; Deng C; Sun L
    Arch Biochem Biophys; 2017 Jun; 623-624():20-30. PubMed ID: 28495512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cisplatin inhibits proliferation of cervical carcinoma cell line by up-regulating Stat1 expression].
    Lei RL; Xiao SS; Xue M
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):88-92. PubMed ID: 25613616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
    Cai L; Wang Z; Liu D
    Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibiting HSP70 expression enhances cisplatin sensitivity of cervical cancer cells].
    Liu J; Liu J; Li SZ; Zheng YA; Guo SY; Wang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):475-481. PubMed ID: 28446399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
    Liu Y; Liu L; Mou ZX
    Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
    Duan W; Liu X
    Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical Cancer Cells.
    Mehta H; Ambele MA; Mokgautsi N; Moela P
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Derived Exosomal miR-651 as a Diagnostic Marker Restrains Cisplatin Resistance and Directly Targets ATG3 for Cervical Cancer.
    Zhu X; Long L; Xiao H; He X
    Dis Markers; 2021; 2021():1544784. PubMed ID: 34567283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
    Zhang R; Shi H; Ren F; Li X; Zhang M; Feng W; Jia Y
    Oncol Rep; 2016 Apr; 35(4):2466-72. PubMed ID: 26794135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome profiling of cervical cancer cells acquired resistance to cisplatin by deep sequencing.
    Wang Y; Liu L; Chen Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2820-2829. PubMed ID: 31293179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.